John Feenstra

586 total citations
15 papers, 264 citations indexed

About

John Feenstra is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, John Feenstra has authored 15 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Cardiology and Cardiovascular Medicine and 4 papers in Genetics. Recurrent topics in John Feenstra's work include Pulmonary Hypertension Research and Treatments (10 papers), Heart Failure Treatment and Management (3 papers) and Cardiovascular Issues in Pregnancy (3 papers). John Feenstra is often cited by papers focused on Pulmonary Hypertension Research and Treatments (10 papers), Heart Failure Treatment and Management (3 papers) and Cardiovascular Issues in Pregnancy (3 papers). John Feenstra collaborates with scholars based in Australia, New Zealand and Netherlands. John Feenstra's co-authors include Paul R. Georghiou, Isabel G. Scalia, D. Burstow, D. Platts, G. Scalia, D. Cross, Edmund Lau, David S. Celermajer, Viviana P. Lutzky and D. Keating and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and International Journal of Cardiology.

In The Last Decade

John Feenstra

14 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Feenstra Australia 9 125 107 87 34 34 15 264
N. Bart Australia 8 98 0.8× 100 0.9× 28 0.3× 66 1.9× 9 0.3× 44 260
Emilio Rivolta Italy 7 29 0.2× 75 0.7× 63 0.7× 67 2.0× 99 2.9× 10 425
Jordi Fontcuberta Spain 6 100 0.8× 48 0.4× 80 0.9× 27 0.8× 19 0.6× 7 426
Mustafa Demirtürk Türkiye 11 44 0.4× 25 0.2× 77 0.9× 15 0.4× 96 2.8× 20 326
Emmanuel Arnaud France 7 123 1.0× 39 0.4× 48 0.6× 25 0.7× 28 0.8× 11 374
F. R. Rosendaal Netherlands 9 152 1.2× 48 0.4× 58 0.7× 18 0.5× 15 0.4× 10 447
Yoshiko Chida Japan 9 70 0.6× 67 0.6× 16 0.2× 25 0.7× 10 0.3× 14 270
Hubert Galinat France 11 66 0.5× 34 0.3× 107 1.2× 34 1.0× 55 1.6× 34 277
Katarzyna Ptaszyńska‐Kopczyńska Poland 10 146 1.2× 88 0.8× 14 0.2× 28 0.8× 20 0.6× 25 258
F. Delwiche Belgium 11 31 0.2× 76 0.7× 56 0.6× 46 1.4× 14 0.4× 15 291

Countries citing papers authored by John Feenstra

Since Specialization
Citations

This map shows the geographic impact of John Feenstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Feenstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Feenstra more than expected).

Fields of papers citing papers by John Feenstra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Feenstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Feenstra. The network helps show where John Feenstra may publish in the future.

Co-authorship network of co-authors of John Feenstra

This figure shows the co-authorship network connecting the top 25 collaborators of John Feenstra. A scholar is included among the top collaborators of John Feenstra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Feenstra. John Feenstra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Brown, Karen, David S. Celermajer, Nicholas Collins, et al.. (2023). Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension Therapy. CHEST Journal. 165(4). 967–977. 3 indexed citations
3.
Anderson, James, Geoff Strange, Nicholas Collins, et al.. (2020). Pulmonary arterial hypertension with below threshold pulmonary vascular resistance. European Respiratory Journal. 56(1). 1901654–1901654. 15 indexed citations
4.
Anderson, James, Melanie Lavender, Edmund Lau, et al.. (2020). Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges. Heart Lung and Circulation. 29(10). 1459–1468. 2 indexed citations
5.
Anderson, James, John Feenstra, D. Keating, et al.. (2020). Pulmonary Arterial Hypertension with Below Threshold Pulmonary Vascular Resistance. A2048–A2048. 1 indexed citations
6.
Chambers, Daniel C., et al.. (2020). Successful treatment of telomeropathy‐related interstitial lung disease with immunosuppression and danazol. Respirology Case Reports. 8(6). e00607–e00607. 12 indexed citations
7.
Fatehi, Farhad, Marlien Varnfield, Hang Ding, et al.. (2020). Use of eHealth in the management of pulmonary arterial hypertension: review of the literature. BMJ Health & Care Informatics. 27(3). e100176–e100176. 11 indexed citations
8.
Feenstra, John, et al.. (2019). Effectiveness of epoprostenol in the management of pulmonary arterial hypertension: findings of an Australian retrospective chart review. Internal Medicine Journal. 50(11). 1377–1384. 3 indexed citations
9.
Morris, Norman, W. Strugnell, Julie Harris, et al.. (2018). Study protocol for a randomised controlled trial of exercise training in pulmonary hypertension (ExTra_PH). BMC Pulmonary Medicine. 18(1). 40–40. 5 indexed citations
10.
Strange, Geoff, Edmund Lau, Eleni Giannoulatou, et al.. (2017). Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand. Heart Lung and Circulation. 27(11). 1368–1375. 24 indexed citations
11.
Scalia, G., Isabel G. Scalia, D. Cross, et al.. (2016). ePLAR — The echocardiographic Pulmonary to Left Atrial Ratio — A novel non-invasive parameter to differentiate pre-capillary and post-capillary pulmonary hypertension. International Journal of Cardiology. 212. 379–386. 40 indexed citations
12.
Dijk, Peter R. van, S. J. J. Logtenberg, Steven H. Hendriks, et al.. (2015). Intraperitoneal versus subcutaneous insulin therapy in the treatment of type 1 diabetes mellitus.. PubMed. 73(9). 399–409. 9 indexed citations
13.
Feenstra, John, et al.. (2014). Pneumocystis jiroveci pneumonitis complicating ruxolitinib therapy. BMJ Case Reports. 2014. bcr2014204950–bcr2014204950. 40 indexed citations
14.
Feenstra, John, et al.. (1998). Angioneurotic Edema Attributed to the Use of Losartan. Archives of Internal Medicine. 158(18). 2063–2063. 87 indexed citations
15.
Slijper, F.M.E., et al.. (1993). Psychosocial Effects of Two Years of Human Growth Hormone Treatment in Turner Syndrome. Hormone Research. 39(2). 56–59. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Bart Breakdown of academic impact, for papers by Emilio Rivolta Breakdown of academic impact, for papers by Jordi Fontcuberta Breakdown of academic impact, for papers by Mustafa Demirtürk Breakdown of academic impact, for papers by Emmanuel Arnaud Breakdown of academic impact, for papers by F. R. Rosendaal Breakdown of academic impact, for papers by Yoshiko Chida Breakdown of academic impact, for papers by Hubert Galinat Breakdown of academic impact, for papers by Katarzyna Ptaszyńska‐Kopczyńska Breakdown of academic impact, for papers by F. Delwiche
Rankless by CCL
2026